| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/13/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G/A
| BRIDGER MANAGEMENT, LLC reports a 0% stake in Consonance-HFW Acquisition Corp. |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/14/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
SC 13G/A
| BRIDGER MANAGEMENT, LLC reports a 1.8% stake in Atara Biotherapeutics, Inc. |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/30/2020 |
SC 13G
| BRIDGER MANAGEMENT, LLC reports a 8.8% stake in Consonance-HFW Acquisition Corp. |
| 11/16/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2020 |
SC 13G/A
| BRIDGER MANAGEMENT, LLC reports a 2.9% stake in Dicerna Pharmaceuticals, Inc. |
| 02/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| BRIDGER MANAGEMENT, LLC reports a 1.9% stake in TG Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| BRIDGER MANAGEMENT, LLC reports a 5.4% stake in Atara Biotherapeutics, Inc. |
| 11/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/01/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 03/11/2019 |
SC 13G
| BRIDGER MANAGEMENT, LLC reports a 5.7% stake in TG Therapeutics, Inc. |
| 02/14/2019 |
SC 13G/A
| BRIDGER MANAGEMENT, LLC reports a 4.6% stake in TG Therapeutics, Inc. |
| 02/14/2019 |
SC 13G/A
| BRIDGER MANAGEMENT, LLC reports a 7.6% stake in Dicerna Pharmaceuticals, Inc. |
| 02/14/2019 |
SC 13G/A
| BRIDGER MANAGEMENT, LLC reports a 4.8% stake in Atara Biotherapeutics, Inc. |
| 02/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/21/2018 |
SC 13G
| BRIDGER MANAGEMENT, LLC reports a 5.8% stake in Dicerna Pharmaceuticals, Inc. |
| 05/15/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|